These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20030517)

  • 21. 3-Amidinophenylalanine-based inhibitors of urokinase.
    Stürzebecher J; Vieweg H; Steinmetzer T; Schweinitz A; Stubbs MT; Renatus M; Wikström P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3147-52. PubMed ID: 10560742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
    Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
    Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-aminoxy acids as building blocks for the oxime and hydroxylamine pseudopeptide links. Application to the synthesis of human elastase inhibitors.
    Vanderesse R; Thevenet L; Marraud M; Boggetto N; Reboud M; Corbier C
    J Pept Sci; 2003 May; 9(5):282-99. PubMed ID: 12803495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular peptides as potential inhibitors of plasmin.
    Markowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2007; 64(4):355-8. PubMed ID: 18536161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.
    de Munk GA; Groeneveld E; Rijken DC
    J Clin Invest; 1991 Nov; 88(5):1680-4. PubMed ID: 1658049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction between heparin and plasmin on amidolysis.
    Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
    Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
    Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease-inhibitory activities of leupeptin analogues.
    Saino T; Someno T; Ishii S; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1988 Feb; 41(2):220-5. PubMed ID: 2965694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boosting the sensitivity of ligand-protein screening by NMR of long-lived states.
    Salvi N; Buratto R; Bornet A; Ulzega S; Rentero Rebollo I; Angelini A; Heinis C; Bodenhausen G
    J Am Chem Soc; 2012 Jul; 134(27):11076-9. PubMed ID: 22686687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-oleoyl heparin inhibits the amidolytic activity of plasmin and urokinase.
    Legras S; Diczhazi C; Moczar M
    Int J Biol Macromol; 1992 Apr; 14(2):97-9. PubMed ID: 1387549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A; Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors.
    Tamura SY; Weinhouse MI; Roberts CA; Goldman EA; Masukawa K; Anderson SM; Cohen CR; Bradbury AE; Bernardino VT; Dixon SA; Ma MG; Nolan TG; Brunck TK
    Bioorg Med Chem Lett; 2000 May; 10(9):983-7. PubMed ID: 10853674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidines.
    Barber CG; Dickinson RP
    Bioorg Med Chem Lett; 2002 Jan; 12(2):185-7. PubMed ID: 11755350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.